1.88
price down icon8.29%   -0.17
after-market Dopo l'orario di chiusura: 1.85 -0.03 -1.60%
loading
Precedente Chiudi:
$2.05
Aprire:
$2.07
Volume 24 ore:
391.13K
Relative Volume:
1.04
Capitalizzazione di mercato:
$99.09M
Reddito:
$1.82M
Utile/perdita netta:
$-267.63M
Rapporto P/E:
-0.0932
EPS:
-20.1639
Flusso di cassa netto:
$-50.53M
1 W Prestazione:
+0.00%
1M Prestazione:
+11.24%
6M Prestazione:
+18.99%
1 anno Prestazione:
-26.99%
Intervallo 1D:
Value
$1.855
$2.0999
Intervallo di 1 settimana:
Value
$1.84
$2.58
Portata 52W:
Value
$1.09
$3.40

Cibus Inc Stock (CBUS) Company Profile

Name
Nome
Cibus Inc
Name
Telefono
(858) 450-0008
Name
Indirizzo
6455 NANCY RIDGE DRIVE, SAN DIEGO
Name
Dipendente
159
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
CBUS's Discussions on Twitter

Confronta CBUS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CBUS
Cibus Inc
1.88 108.05M 1.82M -267.63M -50.53M -20.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
463.86 119.17B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
796.55 84.19B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
398.29 52.77B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
788.49 48.98B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
175.97 36.31B 447.02M -1.18B -906.14M -6.1812

Cibus Inc Stock (CBUS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-29 Iniziato Alliance Global Partners Buy
2024-07-19 Ripresa Canaccord Genuity Buy
2023-10-09 Iniziato H.C. Wainwright Buy
2023-07-19 Ripresa Canaccord Genuity Buy

Cibus Inc Borsa (CBUS) Ultime notizie

pulisher
Jan 08, 2026

Why Cibus Inc. stock is a must watch in 2025Weekly Market Outlook & Short-Term Swing Trade Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Cibus Inc. stock attractive for long term wealth buildingSwing Trade & Fast Entry High Yield Stock Tips - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Cibus Inc. stock maintain dividend yieldJuly 2025 Movers & Weekly Momentum Stock Picks - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Why Cibus Inc. stock attracts global investorsWeekly Stock Analysis & Free Weekly Chart Analysis and Trade Guides - ulpravda.ru

Jan 08, 2026
pulisher
Jan 06, 2026

Cibus repurchases shares from employee in board-approved transaction By Investing.com - Investing.com India

Jan 06, 2026
pulisher
Jan 06, 2026

Cibus repurchases shares from employee in board-approved transaction - Investing.com

Jan 06, 2026
pulisher
Jan 06, 2026

Cibus executes minor internal Class A share repurchase - TipRanks

Jan 06, 2026
pulisher
Jan 06, 2026

Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America - AgriBusiness Global

Jan 06, 2026
pulisher
Jan 06, 2026

Cibus And Interoc Sign LOI To Advance Herbicide-Tolerant Rice Commercialization In Latin America - iGrow News

Jan 06, 2026
pulisher
Jan 05, 2026

Retail Trends: Why Cibus Inc stock is a must watch in 2025Weekly Market Outlook & Daily Profit Maximizing Tips - moha.gov.vn

Jan 05, 2026
pulisher
Jan 05, 2026

Cibus and Interoc sign LOI for herbicide-tolerant rice in Latin America By Investing.com - Investing.com South Africa

Jan 05, 2026
pulisher
Jan 05, 2026

Cibus, Inc. (NASDAQ:CBUS) surges 15%; individual investors who own 43% shares profited along with insiders - Yahoo Finance

Jan 05, 2026
pulisher
Jan 05, 2026

Cibus and Interoc sign LOI for herbicide-tolerant rice in Latin America - Investing.com Canada

Jan 05, 2026
pulisher
Jan 05, 2026

Cibus (CBUS) and Interoc Plan Commercialization of Herbicide-Tol - GuruFocus

Jan 05, 2026
pulisher
Jan 05, 2026

Cibus and Interoc Advance Rice Commercialization Strategy - GlobeNewswire

Jan 05, 2026
pulisher
Jan 04, 2026

Retail investors invested in Cibus, Inc. (NASDAQ:CBUS) up 11% last week, insiders too were rewarded - simplywall.st

Jan 04, 2026
pulisher
Dec 30, 2025

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), UCB SA (GB:0NZT) and Cibus (CBUS) - The Globe and Mail

Dec 30, 2025
pulisher
Dec 29, 2025

Cibus director Prante Gerhard sells $2,875 in stock - MSN

Dec 29, 2025
pulisher
Dec 29, 2025

Short Interest in Cibus, Inc. (NASDAQ:CBUS) Decreases By 32.9% - MarketBeat

Dec 29, 2025
pulisher
Dec 27, 2025

Stock Market Recap: Why Cibus Inc stock is a must watch in 20252025 Volatility Report & Verified Short-Term Plans - moha.gov.vn

Dec 27, 2025
pulisher
Dec 20, 2025

Will Cibus Inc. stock pay special dividendsWeekly Profit Summary & Long-Term Capital Growth Ideas - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Cibus (CBUS) EV-to-OCF : -1.87 (As of Dec. 19, 2025) - GuruFocus

Dec 19, 2025
pulisher
Dec 19, 2025

How Cibus Inc. stock responds to policy changesJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Craig Wichner Net Worth (2025) - GuruFocus

Dec 19, 2025
pulisher
Dec 19, 2025

Will Cibus Inc. stock attract more institutional investorsEarnings Beat & Short-Term Trading Alerts - bolumsonucanavari.com

Dec 19, 2025
pulisher
Dec 18, 2025

Guidance Update: Is Cibus Inc. stock recession proof2025 Trade Ideas & High Conviction Buy Zone Picks - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Is Cibus Inc. stock recession proof2025 Bull vs Bear & Weekly Market Pulse Alerts - Улправда

Dec 18, 2025
pulisher
Dec 13, 2025

Gratia Capital LLC Acquires New Shares in Cibus, Inc. $CBUS - MarketBeat

Dec 13, 2025
pulisher
Dec 12, 2025

Cibus director Prante sells $2,875 in stock - MSN

Dec 12, 2025
pulisher
Dec 11, 2025

Signal Recap: Can Cibus Inc stock maintain growth trajectory2025 Macro Impact & Weekly Return Optimization Alerts - moha.gov.vn

Dec 11, 2025
pulisher
Dec 11, 2025

CBUS FinancialsIncome Statement - Quiver Quantitative

Dec 11, 2025
pulisher
Dec 11, 2025

Cibus (CBUS) Applauds EU Agreement on Gene-Edited Plant Regulati - GuruFocus

Dec 11, 2025
pulisher
Dec 11, 2025

Cibus Welcomes EU Political Agreement on New Genomic Techniques, Supporting Advances in Plant Breeding Innovation - Quiver Quantitative

Dec 11, 2025
pulisher
Dec 11, 2025

Cibus (Nasdaq: CBUS) sees EU NGT agreement advancing gene-edited plant rules - Stock Titan

Dec 11, 2025
pulisher
Dec 11, 2025

Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council - The Manila Times

Dec 11, 2025
pulisher
Dec 09, 2025

Canaccord Genuity Remains a Buy on Cibus (CBUS) - The Globe and Mail

Dec 09, 2025
pulisher
Dec 09, 2025

Cibus’ (CBUS) “Buy” Rating Reaffirmed at Canaccord Genuity Group - Defense World

Dec 09, 2025
pulisher
Dec 08, 2025

Is Cibus Stock Built to Withstand a Pullback? - Trefis

Dec 08, 2025
pulisher
Dec 08, 2025

Canaccord Genuity Maintains Cibus (CBUS) Buy Recommendation - Nasdaq

Dec 08, 2025
pulisher
Dec 08, 2025

Cibus (CBUS) Stock Rating Maintained at "Buy" by Canaccord Genui - GuruFocus

Dec 08, 2025
pulisher
Dec 08, 2025

Cibus (NASDAQ:CBUS) Earns "Buy" Rating from Canaccord Genuity Group - MarketBeat

Dec 08, 2025
pulisher
Dec 02, 2025

ETFs Investing in Cibus, Inc. Stocks - TradingView — Track All Markets

Dec 02, 2025
pulisher
Nov 30, 2025

What drives Cibus Inc stock priceStock Valuation Metrics & Free High Frequency Trading Ideas - earlytimes.in

Nov 30, 2025
pulisher
Nov 29, 2025

Cibus (CBUS) Total Equity : $52.03 Mil (As of Sep. 2025) - GuruFocus

Nov 29, 2025
pulisher
Nov 28, 2025

Cibus (NASDAQ:CBUS) and Brasilagro Cia Brasileira De Propriedades Agricolas (NYSE:LND) Critical Review - Defense World

Nov 28, 2025
pulisher
Nov 27, 2025

Insider Sell: How Cibus Inc. stock responds to policy changesJuly 2025 Sector Moves & Precise Trade Entry Recommendations - moha.gov.vn

Nov 27, 2025
pulisher
Nov 25, 2025

Cibus director Gerhard Prante sells $2,817 in stock - MSN

Nov 25, 2025
pulisher
Nov 25, 2025

Cibus CBUS grants director 45,627 options expiring in 2035 - Stock Titan

Nov 25, 2025
pulisher
Nov 25, 2025

[Form 3] Cibus, Inc. Initial Statement of Beneficial Ownership - Stock Titan

Nov 25, 2025
pulisher
Nov 23, 2025

Cibus (CBUS) Other Stockholders Equity : $0.00 Mil (As of Sep. 2025) - GuruFocus

Nov 23, 2025
pulisher
Nov 22, 2025

Cibus, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo

Nov 22, 2025

Cibus Inc Azioni (CBUS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Cibus Inc Azioni (CBUS) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Prante Gerhard
Director
Feb 24 '25
Sale
2.07
1,150
2,380
8,857
Prante Gerhard
Director
Feb 21 '25
Sale
2.20
1,150
2,530
10,007
Prante Gerhard
Director
Feb 20 '25
Sale
2.35
1,150
2,702
11,157
Prante Gerhard
Director
Feb 19 '25
Sale
2.58
1,150
2,967
12,307
Prante Gerhard
Director
Feb 18 '25
Sale
2.52
2,300
5,796
13,457
Prante Gerhard
Director
Feb 14 '25
Sale
2.60
1,150
2,990
15,757
Prante Gerhard
Director
Feb 13 '25
Sale
2.53
1,150
2,910
16,907
Prante Gerhard
Director
Feb 12 '25
Sale
2.45
1,150
2,818
18,057
Prante Gerhard
Director
Feb 11 '25
Sale
2.48
1,150
2,852
19,207
Prante Gerhard
Director
Feb 10 '25
Sale
2.52
1,150
2,898
20,357
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Capitalizzazione:     |  Volume (24 ore):